Nonspecific increase of systemic neuron-specific enolase after trauma: Clinical and experimental findings

Shock

Volumn 24, Issue 2, 2005, Pages 119-123

  Pelinka, Linda E ^a,b   Hertz, Harald ^b   Mauritz, Walter ^b   Harada, Naoki ^a,c   Jafarmadar, Mohammad ^a   Albrecht, Manfred ^a   Redl, Heinz ^a   Bahrami, Soheyl ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Unfallkrankenhaus Lorenz Bohler   (Austria)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cerebral trauma; Extra cranial trauma; Ischemia; Multiple trauma; Neuron specific enolase; Reperfusion

Indexed keywords

NEURON SPECIFIC ENOLASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; INJURY; INTESTINE INJURY; KIDNEY INJURY; LIVER INJURY; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; TIME SERIES ANALYSIS;

ADULT; ALANINE TRANSAMINASE; ANIMALS; BRAIN INJURIES; CREATININE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; INTESTINES; KIDNEY; LIVER; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; WOUNDS AND INJURIES;

EID: 23344436905     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000168876.68154.43     Document Type: Article

References (32)

1. Snyder-Ramos SA, Bottiger BW: Molecular markers of brain damage: clinical und ethical implications with particular locus on cardiac arrest. Restor Neurol Neurosci 21:123-139, 2003.
2. Fletcher L, Rider CC, Taylor CB: Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase. Biochem Biophys Acta 452:245-252, 1976.
3. Marangos PJ, Sehmechel DE: Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 10:269-295, 1987.
4. Pelinka LE, Toegel E, Mauritz W, Redl H: Serum S100B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 19:195-200, 2003.
5. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G: High serum S100B levels for trauma patients without head injuries. Neurosurgery 48:1255-1258, 2001.
6. Pelinka LE, Harada N. Szalay L, Jafarmadar M, Redl H, Bahrami S: Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 21:72-76, 2004.
7. Kleine TO, Benes L, Zofet P: Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients. Brain Res Bull 61:265-279, 2003.
8. Pelinka LE, Jafarmadar M, Redl H, Bahrami S: Neuron-specific enolase is increased in plasma after hemorrhagic shock and after bilateral femur fracture without traumatic brain injury in rat. Shock 22:88-91, 2005.
9. Sobhian B, Jafarmadar M, Redl H, Bahrami S: Hemorrhage- and resuscitation-related alterations in gastrointestinal circulation: effect of a low dose of L-NMMA. Shock 23:243-247, 2005.
10. Ashburn JH, Baveja R, Kresge N, Korneszczuk K, Keller S, Karaa A, Yokoyama Y, Zhang JX, Huynh T, Clemens MG: Remote trauma sensitizes hepatic microcirculation to endothelin via caveolin inhibition of eNOS activity. Shock 22:120-130, 2004.
11. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM: The role of the complement system in ischemia-reperfusion injury. Shock 21:401-409, 2004.
12. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1:480-484, 1975.
13. Harada N, Okajima K, Kushimoto S: Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med 27:1958-1964, 1999.
14. Pelinka LE, Bahrami S, Szalay L, Umar P, Redl H: Hemorrhagic shock induces an S100B increase associated with shock severity. Shock 19:422-426, 2003.
15. Nygaard O, Langbakk B, Romner B: Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scand J Clin Lab Invest 58:183-186, 1998.
16. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 18:911-918, 1987.
17. Fogel W, Krieger D, Veith M, Adams HP, Hund E, Storch-Hagenlocher B, Buggle F, Mathias D, Hacke W: Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 25:1133-1138, 1997.
18. Oh SH, Lee JG, Na SJ, Park JH, Choi YC, Kim WJ: Prediction of early clinical seventy and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level. Arch Neurol 60:37-41, 2003.
19. Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN: Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30:1598-1603, 1999.
20. Herrmann M, Jost S, Kutz S, Ebert AD, Kratz T, Wunderlich MT, Synowitz H: Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 17:113-122, 2000.
21. Meynaar IA, Straaten HM, van der Wetering J, Verlooy P, Slaats EH, Bosman RJ, van der Spoel JI, Zandstra DF: Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med 29:189-195, 2003.
22. Tiainen M, Roine RO, Pettila V, Takkunen O: Serum neuron-specific enolase and S-100 protein in cardiac arrest patients treated with hypothermia. Stroke 34:2881-2886, 2003.
23. Schmechel D, Marangos PJ, Brightman M: Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 276:834-836, 1978.
24. Cooper EH: Neuron-specific enolase. Int J Biol Markers 9:205-210, 1994.
25. Cucullo L, McAllister MS, Kight K, Krizanac-Bengez L, Marroni M, Mayberg MR, Stanness KA, Janigro D: A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier. Brain Res 951:243-254, 2002.
26. Bradley HE, Fitch W: Biochemical markers of cerebral ischaemia. In Sebel PS, Fitch W (eds.): Monitoring the Central Nervous System. Blackwell Science. 1994, pp 26-50.
27. Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, Mutschler W, Jochum M: Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock 18:395-400, 2002.
28. Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg MR, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D: Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 21:109-121, 2003.
29. Woertgen C, Rothoerl RD, Brawanski A: Neuron-specific enolase serum levels after controlled cortical impact injury in the rat. J Neurotrauma 18:569-573, 2001.
30. Day IN, Thompson RJ: Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells. Clin Chim Acta 136:219-228, 1984.
31. Bock E, Dissing J: Demonstration of enolase activity connected to the brain specific protein 14-3-2. Scand J Immunol 4:31-36, 1975.
32. Christensen EI, Nielsen S: Structural and functional features of protein handling in the kidney proximal tubule. Semin Nephrol 11:414-439, 1991.